Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies

Table 1 PACS questionnaire

	Questions
1	Have you previously tested positive for COVID-19?			Yes	No
2	Have you fully recovered from your COVID-19 illness?			Yes	No
Are you currently experiencing any of the following
3	Fatigue or tiredness that persists even after rest or sleep?			Yes	No
4	Difficulty breathing or shortness of breath?			Yes	No
5	Pain or pressure in the chest?			Yes	No
6	Joint or muscle pain?			Yes	No
7	Headaches?			Yes	No
8	Difficulty concentrating or mental confusion?			Yes	No
9	Loss of taste or smell?			Yes	No
10	Digestive problems such as nausea, vomiting, or diarrhea?			Yes	No
11	Skin rashes or lesions?			Yes	No
12	Mood changes such as depression, anxiety, or irritability?			Yes	No
13	If you answered yes to any of the above symptoms, how long have you been experiencing these symptoms?	< 1wk	1–3 wk	3–6 wk	> 6 wk
14	Have these symptoms affected your ability to perform daily activities or work?			Yes	No
15	Have you sought medical attention for these symptoms?			Yes	No
16	Have you received any treatment for these symptoms?			Yes	No
17	Is there anything else you would like to share about your symptoms or experience with COVID-19?			Yes	No

ISSN: 1471-2334